Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001567619-22-004884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $1.16 | +17.0K | 114.7K | +17% | +$19.7K |
| D | 2022-02-17 | 2022-02-15 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | S - Sale+OE | $95.13 | -17.0K | 97.7K | -15% | -$1.62M |
| D | 2022-02-17 | 2022-02-15 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $0.00 | -17.0K | 392.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-15 | M | A | 17,000 | $1.16 | 114,653 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-15 | S | D | 17,000 | $95.13 | 97,653 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $95.00 to $95.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Derivative | Stock Option (right to buy) | 2022-02-15 | M | D | 17,000 | $0.00 | 392,000 | D | $1.16 · — to 2027-02-03 | 17,000 Class A Common Stock | (F3) This option, originally for 800,000 shares, of which 408,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |